Hiroaki Hiraga

2.6k total citations
62 papers, 1.5k citations indexed

About

Hiroaki Hiraga is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Rheumatology. According to data from OpenAlex, Hiroaki Hiraga has authored 62 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Pulmonary and Respiratory Medicine, 29 papers in Oncology and 15 papers in Rheumatology. Recurrent topics in Hiroaki Hiraga's work include Sarcoma Diagnosis and Treatment (43 papers), Vascular Tumors and Angiosarcomas (18 papers) and Bone Tumor Diagnosis and Treatments (14 papers). Hiroaki Hiraga is often cited by papers focused on Sarcoma Diagnosis and Treatment (43 papers), Vascular Tumors and Angiosarcomas (18 papers) and Bone Tumor Diagnosis and Treatments (14 papers). Hiroaki Hiraga collaborates with scholars based in Japan, United States and Hong Kong. Hiroaki Hiraga's co-authors include Kazuo Nagashima, Takafumi Ueda, Hirofumi Sawa, Takayuki Nojima, Akira Kawai, Akihiko Matsumine, Tsukasa Yonemoto, Nobuhito Araki, Hideshi Sugiura and Shinya Yamawaki and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Cancer.

In The Last Decade

Hiroaki Hiraga

58 papers receiving 1.5k citations

Peers

Countries citing papers authored by Hiroaki Hiraga

Since Specialization

Citations

This map shows the geographic impact of Hiroaki Hiraga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Hiraga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Hiraga more than expected).

Fields of papers citing papers by Hiroaki Hiraga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Hiraga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Hiraga. The network helps show where Hiroaki Hiraga may publish in the future.

Co-authorship network of co-authors of Hiroaki Hiraga

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Hiraga. A scholar is included among the top collaborators of Hiroaki Hiraga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Hiraga. Hiroaki Hiraga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Recovery of ambulation in older adults undergoing fracture surgery for femoral metastasis: a multicenter retrospective cohort study 2025 ·Scientific Reports ·Kanako Ito, Hirokazu Shimizu, Masatake Matsuoka, Tamotsu Soma, Daisuke Takahashi, Tomohiro Shimizu, (unknown), Hiroaki Hiraga, Norimasa Iwasaki, Akira Iwata	0
2	Intervention for impending pathological fractures at proximal femur is associated with lower mortality rates in patients with intermediate-to-high risk according to the Katagiri-New score 2024 ·BMC Musculoskeletal Disorders ·(unknown), Hirokazu Shimizu, Masatake Matsuoka, Daisuke Takahashi, Tomohiro Shimizu, Norimasa Iwasaki, Ken Kuwahara, Tamotsu Soma, Hiroaki Hiraga, Akira Iwata	1
3	Final results of a randomized phase II/III study comparing perioperative adriamycin plus ifosfamide and gemcitabine plus docetaxel for high-grade soft tissue sarcomas: Japan Clinical Oncology Group study JCOG1306. 2024 ·Journal of Clinical Oncology ·Kazuhiro Tanaka, Ryunosuke Machida, Makoto Endo, Akira Kawai, Robert Nakayama, Satoshi Tsukushi, Kunihiro Asanuma, Hiroaki Hiraga, Koji Hiraoka, Shinichiro Yoshida, Tsukasa Yonemoto, Jungo Imanishi, Hirohisa Katagiri, Yoshihiro Nishida, Akihito Nagano, Yuta Sekino, Haruhiko Fukuda, Toshifumi Ozaki, Yukihide Iwamoto, (unknown)	1
4	Results of a randomized phase II trial of 2nd-line treatment for advanced soft tissue sarcoma comparing trabectedin, eribulin and pazopanib: Japan Clinical Oncology Group study JCOG1802 (2ND-STEP). 2024 ·Journal of Clinical Oncology ·Makoto Endo, Toshifumi Fujiwara, Masanobu Takahashi, Satoshi Tsukushi, Akira Kawai, Tabu Gokita, Fumihiko Nakatani, Yutaka Nezu, Takaaki Tanaka, Kenji Nakano, Hiroaki Hiraga, Masashi Wakabayashi, Tomoko Kataoka, (unknown), Haruhiko Fukuda, Yoshinao Oda, Toshifumi Ozaki, Kazuhiro Tanaka	1
5	Japanese orthopaedic association (JOA) clinical practice guideline on the management of primary malignant bone tumors - Secondary publication 2024 ·Journal of Orthopaedic Science ·Kazuaki Tsuchiya, Toshihiro Akisue, (unknown), Akira Kawai, Hirotaka Kawano, Hiroaki Hiraga, Ako Hosono, (unknown), Takeshi Morii, Hideo Morioka, Yoshihiro Nishida, Yoshinao Oda, Akira Ogose, Shoji Shimose, Takehiko Yamaguchi, Tetsuji Yamamoto, (unknown)	1
6	Development of a population pharmacokinetics and pharmacodynamics model of glucarpidase rescue treatment after high-dose methotrexate therapy 2023 ·Frontiers in Oncology ·(unknown), Toshimi Kimura, (unknown), Kenichi Yoshimura, Hiroaki Hiraga, Yuki Yuza, (unknown), Junichi Hara, Katsuyoshi Koh, Atsushi Kikuta, Yuhki Koga, Hiroshi Kawamoto	1
7	Impact of Smoking History on Pulmonary Metastasis-free Survival in Patients With Soft-tissue Sarcoma 2021 ·Cancer Diagnosis & Prognosis ·Masatake Matsuoka, Masanori Okamoto, Tamotsu Soma, Isao Yokota, (unknown), Tomohiro Onodera, Eiji Kondo, Norimasa Iwasaki, Hiroaki Hiraga	6
8	Time lapse analysis of tumor response in patients with soft tissue sarcoma treated with trabectedin: A pooled analysis of two phase II clinical trials 2020 ·Cancer Medicine ·Makoto Endo, Shunji Takahashi, Nobuhito Araki, Hideshi Sugiura, Takafumi Ueda, Tsukasa Yonemoto, Mitsuru Takahashi, Hideo Morioka, Hiroaki Hiraga, Toru Hiruma, Toshiyuki Kunisada, Akihiko Matsumine, (unknown), Akira Kawai	7
9	Metastases of soft tissue sarcoma to the liver: A Historical Cohort Study from a Hospital‐based Cancer Registry 2020 ·Cancer Medicine ·Masanori Okamoto, Masatake Matsuoka, Tamotsu Soma, (unknown), Hidenori Kato, Toru Harabayashi, (unknown), Toshiki Shinohara, Tamotsu Sagawa, (unknown), Toshikazu Nambu, (unknown), Hiroaki Suzuki, Hiroyuki Kato, Hiroaki Hiraga	14
10	Phase II trial of pazopanib in patients with metastatic or unresectable chemoresistant sarcomas: A Japanese Musculoskeletal Oncology Group study 2020 ·Cancer Science ·Hiroshi Urakawa, Akira Kawai, Takahiro Goto, Hiroaki Hiraga, Toshifumi Ozaki, Hiroyuki Tsuchiya, Robert Nakayama, Norifumi Naka, Yoshihiro Matsumoto, Eisuke Kobayashi, Tomotake Okuma, (unknown), Masahiko Ando, Takafumi Ueda, Yoshihiro Nishida	12
11	A randomized, double-blind, placebo-controlled, Phase III study of pazopanib in patients with soft tissue sarcoma: results from the Japanese subgroup 2016 ·Japanese Journal of Clinical Oncology ·Akira Kawai, Nobuhito Araki, Hiroaki Hiraga, Hideshi Sugiura, Akihiko Matsumine, Toshifumi Ozaki, Takafumi Ueda, Takeshi Ishii, Taito Esaki, (unknown), (unknown)	30
12	Feasibility and efficacy of gemcitabine and docetaxel combination chemotherapy for bone and soft tissue sarcomas: multi-institutional retrospective analysis of 134 patients 2016 ·World Journal of Surgical Oncology ·Kazuhiro Tanaka, Susumu Joyama, Hirokazu Chuman, Hiroaki Hiraga, Hideo Morioka, Hideki Yoshikawa, Masami Hosaka, Mitsuru Takahashi, Tadahiko Kubo, Koji Hatano, Mitsunori Kaya, Junya Toguchida, Yoshihiro Nishida, Akihito Nagano, Hiroshi Tsumura, Yukihide Iwamoto	11
13	Identification and analysis of CXCR4-positive synovial sarcoma-initiating cells 2015 ·Oncogene ·Taichi Kimura, (unknown), Kouichi Tabu, Masumi Tsuda, Mishie Tanino, Akira Maekawa, Hiroshi Nishihara, Hiroaki Hiraga, Tetsuya Taga, Yoshinao Oda, Shinya Tanaka	20
14	The posterior thigh flap revisited: clinical use in oncology patients 2013 ·Surgery Today ·Akira Saito, Hidehiko Minakawa, Noriko Saito, Kazuo Isu, Hiroaki Hiraga, Toshihisa Osanai	7
15	The melanocyte inducing factor MITF is stably expressed in cell lines from human clear cell sarcoma 2003 ·British Journal of Cancer ·(unknown), Jane Goodall, Colin R. Goding, (unknown), Chenghui Wang, (unknown), Hiroaki Hiraga, Takayuki Nojima, K Nagashima, (unknown), (unknown)	30
16	Increased pre-therapeutic serum vascular endothelial growth factor in patients with early clinical relapse of osteosarcoma 2002 ·British Journal of Cancer ·Mitsunori Kaya, Takuro Wada, Satoshi Kawaguchi, Satoshi Nagoya, Toshihiko Yamashita, Yoshiyuki Abe, Hiroaki Hiraga, Kazuo Isu, Masanobu Shindoh, Fumihiro Higashino, Futoshi Okada, Mitsuhiro Tada, Shinya Yamawaki, Shoken Ishii	62
17	Histological and Molecular Evidence of Synovial Sarcoma of Bone. A Case Report* 1999 ·Journal of Bone and Joint Surgery ·Hiroaki Hiraga, Takayuki Nojima, Kazuo Isu, Katsushige Yamashiro, Shinya Yamawaki, Kazuo Nagashima	34
18	Neoadjuvant Chemotherapy for Osteosarcoma : The Current and the Prospect 1998 ·Journal of Orthopaedic Science ·Kazuo Isu, Shinya Yamawaki, Hiroaki Hiraga, (unknown)	1
19	Neuropathological and molecular studies of spinocerebellar ataxia type 6 (SCA6) 1998 ·Acta Neuropathologica ·Hidenao Sasaki, Hideaki Kojima, Ichiro Yabe, Kunio Tashiro, Takeshi Hamada, Hirofumi Sawa, Hiroaki Hiraga, Kazuki Nagashima	79
20	Establishment of a new continuous clear cell sarcoma cell line 1997 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Hiroaki Hiraga, Takayuki Nojima, Syuiti Abe, Katsushige Yamashiro, Shinya Yamawaki, (unknown), Kazuo Nagashima	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact